Cargando…

Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review

Identifying patients at risk of exacerbations and managing them appropriately to reduce this risk represents an important clinical challenge. Numerous treatments have been assessed for the prevention of exacerbations and their efficacy may differ by patient phenotype. Given their centrality in the t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miravitlles, Marc, D’Urzo, Anthony, Singh, Dave, Koblizek, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018159/ https://www.ncbi.nlm.nih.gov/pubmed/27613392 http://dx.doi.org/10.1186/s12931-016-0425-5

Ejemplares similares

Weighing the evidence for pharmacological treatment interventions in mild COPD; a narrative perspective
por: Singh, Dave, et al.
Publicado: (2019)

Use of concomitant inhaled corticosteroids: pooled data from two phase III studies of aclidinium plus formoterol in COPD
por: D’Urzo, Anthony, et al.
Publicado: (2017)

Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD
por: D’Urzo, Anthony
Publicado: (2013)

Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
por: D’Urzo, Anthony D., et al.
Publicado: (2019)

Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT)
por: Bateman, Eric D., et al.
Publicado: (2015)

Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
por: D’Urzo, Anthony D, et al.
Publicado: (2018)

A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease
por: D’Urzo, Anthony, et al.
Publicado: (2015)

Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD
por: Miravitlles, Marc
Publicado: (2007)

Optimizing bronchodilation in the prevention of COPD exacerbations
por: Miravitlles, Marc, et al.
Publicado: (2017)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Is the family physician an accomplice in the development of the ‘primary care gap’? The importance of high quality real-life primary care respiratory research
por: D'Urzo, Anthony
Publicado: (2013)

An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPD
por: Singh, Dave, et al.
Publicado: (2019)

Comparison of glycopyrronium versus tiotropium on the time to clinically important deteriorations in patients with COPD: a post-hoc analysis of randomized trials
por: D’Urzo, Anthony, et al.
Publicado: (2018)

Efficacy of aclidinium/formoterol 400/12 µg, analyzed by airflow obstruction severity, age, sex, and exacerbation history: pooled analysis of ACLIFORM and AUGMENT
por: D’Urzo, Anthony D, et al.
Publicado: (2019)

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
por: D’Urzo, Anthony, et al.
Publicado: (2019)

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials
por: Singh, Dave, et al.
Publicado: (2020)

Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol
por: Singh, Dave, et al.
Publicado: (2017)

New developments in optimizing bronchodilator treatment of COPD: a focus on glycopyrrolate/formoterol combination formulated by co-suspension delivery technology
por: D’Urzo, Anthony D, et al.
Publicado: (2018)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment
por: Aisanov, Zaurbek, et al.
Publicado: (2018)

Management of severe acute exacerbations of COPD: an updated narrative review
por: Crisafulli, Ernesto, et al.
Publicado: (2018)

Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
por: Singh, Dave, et al.
Publicado: (2021)

POPE study: rationale and methodology of a study to phenotype patients with COPD in Central and Eastern Europe
por: Zbozinkova, Zuzana, et al.
Publicado: (2016)

The challenge of objective confirmation of asthma diagnosis in primary care
por: Kaicker, Jatin, et al.
Publicado: (2014)

Independent effect of prior exacerbation frequency and disease severity on the risk of future exacerbations of COPD: a retrospective cohort study
por: Margüello, Miguel Santibañez, et al.
Publicado: (2016)

Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
por: D’Urzo, Anthony D, et al.
Publicado: (2014)

Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data
por: D’Urzo, Anthony D, et al.
Publicado: (2015)

Update on Asthma–COPD Overlap (ACO): A Narrative Review
por: Mekov, Evgeni, et al.
Publicado: (2021)

Thiazolidinediones are associated with a reduced risk of COPD exacerbations
por: Rinne, Seppo T, et al.
Publicado: (2015)

Prognostic factors for clinical failure of exacerbations in elderly outpatients with moderate-to-severe COPD
por: Wilson, Robert, et al.
Publicado: (2015)

Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial
por: D'Urzo, Anthony, et al.
Publicado: (2011)

Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis
por: Alqahtani, Jaber S., et al.
Publicado: (2021)

Diagnosing COPD: advances in training and practice – a systematic review
por: Koblizek, Vladimir, et al.
Publicado: (2016)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

Strategies for improving outcomes of COPD exacerbations
por: Wilkinson, Tom, et al.
Publicado: (2006)

Burden of Disease Among Exacerbating Patients with COPD Treated with Triple Therapy in Spain
por: Alcázar-Navarrete, Bernardino, et al.
Publicado: (2021)

A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
por: Wilson, Robert, et al.
Publicado: (2011)

Moxifloxacin versus amoxicillin/clavulanic acid in outpatient acute exacerbations of COPD: MAESTRAL results
por: Wilson, Robert, et al.
Publicado: (2012)

Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME study
por: Vogelmeier, Claus F, et al.
Publicado: (2018)

Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial
por: Nathan, Robert A, et al.
Publicado: (2012)

Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life
por: Miravitlles, Marc, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_p0knksc7s86444v9780401fnuj